LIMN
Liminatus Pharma·NASDAQ
--
--(--)
--
--(--)
LIMN fundamentals
Liminatus Pharma (LIMN) released its earnings on Apr 18, 2022: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Apr 18, 2022
EPS
Actual | |
Forecast | |
Surprise | 0.00% |
Revenue
Actual | -- |
Forecast | -- |
Surprise | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Liminatus Pharma's revenue and profit?What were the key takeaways from Liminatus Pharma's earnings call?What were the key takeaways from Liminatus Pharma’s earnings call?Did Liminatus Pharma beat or miss consensus estimates last quarter?What does Liminatus Pharma do and what are its main business segments?What is Liminatus Pharma's latest dividend and current dividend yield?What guidance did Liminatus Pharma's management provide for the next earnings period?What is the market's earnings forecast for Liminatus Pharma next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
